159 related articles for article (PubMed ID: 2179758)
1. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
Mactier RA; Moore H; Khanna R; Shah J
Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin absorption from the peritoneal cavity during dialysis-related peritonitis.
Rubin J
Perit Dial Int; 1990; 10(4):283-5. PubMed ID: 2096929
[TBL] [Abstract][Full Text] [Related]
3. Effect of peritonitis on peritoneal transport characteristics: glucose solution versus polyglucose solution.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 2000 Apr; 57(4):1704-12. PubMed ID: 10760106
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal abnormalities during infectious episodes of continuous ambulatory peritoneal dialysis.
Rubin J; Ray R; Barnes T; Bower J
Nephron; 1981; 29(3-4):124-7. PubMed ID: 7329486
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of transperitoneal insulin transport.
Widerøe TE; Dahl KJ; Smeby LC; Balstad T; Cruischank-Flakne S; Følling I; Simondsen O; Ahlmen J; Jørstad S
Nephron; 1996; 74(2):283-90. PubMed ID: 8893142
[TBL] [Abstract][Full Text] [Related]
6. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
Pantsulaia T; Chokhonelidze I; Lomitashvili T
Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
[TBL] [Abstract][Full Text] [Related]
7. [Changes in residual dextrose and amount of total protein loss in the effluent during the clinical course of continuous ambulatory peritoneal dialysis-related peritonitis].
Wakabayashi Y
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1175-83. PubMed ID: 7815750
[TBL] [Abstract][Full Text] [Related]
8. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
Coban E; Ozdogan M; Tuncer M; Bozcuk H; Ersoy F
J Nephrol; 2004; 17(3):427-30. PubMed ID: 15365965
[TBL] [Abstract][Full Text] [Related]
9. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
[No Abstract] [Full Text] [Related]
11. Hyaluronan prevents the decreased net ultrafiltration caused by increased peritoneal dialysate fill volume.
Wang T; Cheng HH; Heimbürger O; Waniewski J; Bergström J; Lindholm B
Kidney Int; 1998 Feb; 53(2):496-502. PubMed ID: 9461112
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
[TBL] [Abstract][Full Text] [Related]
13. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
14. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
Thorp ML; Wilks TS
Am J Kidney Dis; 2004 May; 43(5):927-9. PubMed ID: 15112185
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis.
Davies SJ; Bryan J; Phillips L; Russell GI
Nephrol Dial Transplant; 1996 Mar; 11(3):498-506. PubMed ID: 8671821
[TBL] [Abstract][Full Text] [Related]
17. Administration of insulin by continuous ambulatory peritoneal dialysis.
Chan E; Montgomery PA
Pharmacotherapy; 1993; 13(5):455-60. PubMed ID: 8247911
[TBL] [Abstract][Full Text] [Related]
18. Ultrafiltration failure and dialysate glucose in CAPD.
Stegmayr B; Granbom L; Karlsson UM; Lindqvist B
Adv Perit Dial; 1993; 9():62-4. PubMed ID: 8105964
[TBL] [Abstract][Full Text] [Related]
19. Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease.
Amair P; Khanna R; Leibel B; Pierratos A; Vas S; Meema E; Blair G; Chisolm L; Vas M; Zingg W; Digenis G; Oreopoulos D
N Engl J Med; 1982 Mar; 306(11):625-30. PubMed ID: 7035945
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal insulin in uraemic diabetics undergoing continuous ambulatory peritoneal dialysis.
Balducci A; Slama G; Rottembourg J; Baumelou A; Delage A
Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1021-3. PubMed ID: 6794746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
